Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
Clinical trial NCT01370317 · COMPLETED
Trial details
- NCT number
- NCT01370317
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2011-12-27
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.